(Q36872332)

16 August 2017

1 reference

title

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design (English)

1 reference

16 August 2017

1 reference

Parren PW

1

1 reference

16 August 2017

Gauduin MC

2

1 reference

16 August 2017

Koup RA

3

1 reference

16 August 2017

Poignard P

4

1 reference

16 August 2017

Fisicaro P

5

1 reference

16 August 2017

Burton DR

6

1 reference

16 August 2017

Sattentau QJ

7

1 reference

16 August 2017

1 June 1997

1 reference

16 August 2017

1 reference

16 August 2017

57

1 reference

16 August 2017

105-112

1 reference

16 August 2017

1-3

1 reference

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Epitope exposure on functional, oligomeric HIV-1 gp41 molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

A general model for the transmembrane proteins of HIV and other retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Oligomerization of the hydrophobic heptad repeat of gp41.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

A general model for the surface glycoproteins of HIV and other retroviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Jitters jeopardize AIDS vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarifications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

The role of the V3 loop of gp120 in HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Human immunodeficiency virus infection of human-PBL-SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Pre- and postexposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Defining antibody protection against HIV-1 transmission in Hu-PBL-SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Follicular dendritic cells and human immunodeficiency virus infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

HIV-1 antibody--debris or virion?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Predetermination by infection and by vaccination of antibody response to influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Disquisitions of Original Antigenic Sin. I. Evidence in man

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Disquisitions on Original Antigenic Sin. II. Proof in lower creatures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Characterization by serial deletion competition ELISAs of HIV-1 V3 loop epitopes recognized by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900043-6

7 January 2021

10.1016/S0165-2478(97)00043-6

Identifiers

DOI

1 reference

16 August 2017

1 reference